EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Yong Li(Baylor College of Medicine), Ken H. Young(Duke Medical Center), Fredrick B. Hagemeister(The University of Texas MD Anderson Cancer Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Heounjeong Go(Ulsan College), Zenggang Pan(University of Colorado Anschutz Medical Campus), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Yingjun Wang(South China University of Technology), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Shanxiang Zhang(Indiana University School of Medicine), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Aliyah R. Sohani(Massachusetts General Hospital), Mingzhi Zhang(Chinese Academy of Sciences), Jeremy S. Abramson(Massachusetts General Hospital), Min Xu(Yale University), Jane N. Winter(Northwestern University)
Cited by 18
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k